Savara Inc (SVRA)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

900 S. CAPITAL OF TEXAS HIGHWAY AUSTIN, TX 78746

Savara is an orphan lung disease company. Its lead program, molgramostim, is an inhaled granulocyte-macrophage colony-stimulating factor (GM-CSF) in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). Its management team has significant experience in orphan drug development and pulmonary medicine, identifying unmet needs, and effectively advancing product candidates to approval and commercialization.

Data as of 2021-08-02 08:26:35 -0400
Market Cap145.728 Million Shares Outstanding113.85 Million Avg 30-day Volume461.544 Thousand
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-0.03 Enterprise Value
Total Cash Current Debt Gross Profit
BETA1.03549 52-week High/Low3.58 / 0.9952 Next Earnings Date2021-08-05 Price to Cash FLow (P/CF) -9.0667
Data provided by IEX Cloud
View SEC Filings from SVRA instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 1 0 0 (0.0%) 0 (0.0%)
Funds Holding: 83 67 23.88% 25 (1.47%) 19 (1.1%) 31.58%
13F shares: 75.346 Million 21.66 Million 247.85% 18.124 Million 6.714 Million 169.92%
% Ownership 40.0071 33.4161 12.4018 169.45%
New Positions: 25 8 212.5% 12 3 300.0%
Increased Positions 23 17 35.29% 6 3 100.0%
Closed Positions 9 12 -25.0% 6 7 -14.29%
Reduced Positions 15 19 -21.05% 3 7 -57.14%
Total Calls 292.794 Thousand 75.132 Thousand 289.71% 56 Thousand 49.2 Thousand 13.82%
Total Puts 201.569 Thousand 97.6 Thousand
PUT/CALL Ratio 0.69 0.0 1.74 0.0
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding SVRA (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding SVRA BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

PAULS MATTHEW CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
318,122 2021-05-21 5

RAMSAY DAVID A

  • Director
866,800 2021-05-19 4

CHOWDHURY BADRUL A. CHIEF MEDICAL OFFICER

  • Officer
150,000 2021-05-15 2

MCCRACKEN JOSEPH S

  • Director
168,337 2021-03-15 2

LOWRANCE DAVID L CHIEF FINANCIAL OFFICER

  • Officer
13,793 2021-03-15 2

GROWTH EQUITY OPPORTUNITIES 17, LLC

NEW ENTERPRISE ASSOCIATES 17, L.P.

NEA PARTNERS 17, L.P.

NEA 17 GP, LLC

  • 10% Owner
24,137,931 2021-03-15 1

BASKETT FOREST

  • 10% Owner
24,137,931 2021-03-15 1

BEHBAHANI ALI

  • 10% Owner
24,137,931 2021-03-15 1

CHANG CARMEN

  • 10% Owner
24,137,931 2021-03-15 1

FLORENCE ANTHONY A. JR.

  • 10% Owner
24,137,931 2021-03-15 1

LANDSMAN LIZA

  • 10% Owner
24,137,931 2021-03-15 1

MAKHZOUMI MOHAMAD

  • 10% Owner
24,137,931 2021-03-15 1

MAKOWER JOSHUA

  • 10% Owner
24,137,931 2021-03-15 1

MATHERS EDWARD T

  • 10% Owner
24,137,931 2021-03-15 1

SANDELL SCOTT D

  • 10% Owner
24,137,931 2021-03-15 1

SONSINI PETER W.

  • 10% Owner
24,137,931 2021-03-15 1

WALKER PAUL EDWARD

  • 10% Owner
24,137,931 2021-03-15 1

YANG RICK

  • 10% Owner
24,137,931 2021-03-15 1

HAWKINS RICHARD J

  • Director
0 2020-12-16 1

VAN ES-JOHANSSON AN

  • Director
0 2020-12-16 1

SUN RICKY

  • Director
0 2020-12-16 1

ELAM NEVAN C

  • Director
24,612 2020-12-15 1

JOUHIKAINEN JAAKKO TANELI SEE REMARKS

  • Officer
0 2019-12-20 0

NEVILLE ROBERT N CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
0 2019-12-20 0

PIKOVER YURI

  • Director
0 2018-12-13 0

ZAMBON CO SPA

ZAMBON SPA

  • 10% Owner
4,693,540 2017-06-07 0

SERENOVA A/S

  • 10% Owner
1,965,400 2017-04-27 0

CULLEY BRIAN M CEO AND DIRECTOR

  • Officer
  • Director
0 2017-01-20 0

ROBERTS BRANDI CHIEF FINANCIAL OFFICER & SVP

  • Officer
0 2017-01-20 0

DITTRICH HOWARD

  • Director
0 2017-01-20 0

PARSLEY EDWIN L. CHIEF MEDICAL OFFICER & SVP

  • Officer
0 2017-01-20 0

GREENLEAF PETER

  • Director
0 2017-01-20 0

HOOD SHANA GENERAL COUNSEL & VP

  • Officer
0 2017-01-20 0

EMANUELE ROBERT MARTIN SENIOR VP, DEVELOPMENT

  • Officer
0 2016-01-04 0

GORGAS GREGORY D. SENIOR VP, COMMERCIAL

  • Officer
0 2016-01-04 0

LIEF JACK

  • Director
0 2015-06-11 0

SHUSTER LEWIS

  • Director
0 2015-06-11 0

KERAN PATRICK L PRESIDENT & COO

  • Officer
0 2015-01-02 0

VETTICADEN SANTOSH CHIEF MEDICAL OFFICER & SVP

  • Officer
0 2014-06-19 0

LOVE TED W

  • Director
0 2013-06-19 0

ROWINSKY ERIC K

  • Director
0 2010-06-30 0

PYKETT MARK JEROME

  • Director
0 2010-06-30 0

GOLDBERG MICHAEL M

  • Director
0 2010-06-30 0

KOSTAS ODYSSEAS D

  • Director
0 2010-06-30 0

DENNER ALEXANDER J

  • Director
No longer subject to file 2009-10-16 0

YELMENE MICHELE VP, REGULATORY & QA

  • Officer
0 2009-01-30 0

ERWIN MARK E. SVP, OPERATIONS

  • Officer
0 2009-01-30 0

ROBBINS JOAN M CSO, SR. VP

  • Officer
156,500 2008-05-13 0

BAGNALL MARK CFO & EXECUTIVE VICE PRESIDENT

  • Officer
  • Director
0 2008-04-03 0

SCHUPP JOACHIM PH VP, MEDICAL AFFAIRS

  • Officer
0 2008-03-31 0

LEVINE EVAN CEO & PRESIDENT

  • Officer
  • Director
4,395,000 2008-02-08 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
SAVARA INC SVRA 2021-08-02 22:15:03 UTC -0.4265 0.4865 1000000
SAVARA INC SVRA 2021-08-02 21:45:03 UTC -0.4265 0.4865 1000000
SAVARA INC SVRA 2021-08-02 21:15:03 UTC -0.4265 0.4865 1000000
SAVARA INC SVRA 2021-08-02 20:45:03 UTC -0.4676 0.5276 1000000
SAVARA INC SVRA 2021-08-02 20:15:03 UTC -0.4676 0.5276 1000000
SAVARA INC SVRA 2021-08-02 19:45:03 UTC -0.4676 0.5276 1000000
SAVARA INC SVRA 2021-08-02 19:15:03 UTC -0.4676 0.5276 1000000
SAVARA INC SVRA 2021-08-02 18:45:03 UTC -0.4676 0.5276 1000000
SAVARA INC SVRA 2021-08-02 18:15:03 UTC -0.4676 0.5276 1000000
SAVARA INC SVRA 2021-08-02 17:45:03 UTC -0.4676 0.5276 1000000
SAVARA INC SVRA 2021-08-02 17:15:03 UTC -0.4676 0.5276 1000000
SAVARA INC SVRA 2021-08-02 16:45:03 UTC -0.4476 0.5276 1000000
SAVARA INC SVRA 2021-08-02 16:15:03 UTC -0.4476 0.5276 1000000
SAVARA INC SVRA 2021-08-02 15:45:03 UTC -0.4476 0.5276 1000000
SAVARA INC SVRA 2021-08-02 15:15:03 UTC -0.4476 0.5276 1000000
SAVARA INC SVRA 2021-08-02 14:45:03 UTC -0.4268 0.5068 1000000
SAVARA INC SVRA 2021-08-02 14:15:03 UTC -0.4268 0.5068 1000000
SAVARA INC SVRA 2021-08-02 13:45:03 UTC -0.4268 0.5068 1000000
SAVARA INC SVRA 2021-08-02 13:15:04 UTC -0.4268 0.5068 1000000
SAVARA INC SVRA 2021-08-02 12:45:03 UTC -0.4268 0.5068 1000000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments